NCT02679183

Brief Summary

Honey is a natural product that contains multiple nutrients; it is composed of fructose, glucose and fructooligosaccharides that can potentially serve prebiotic functions. It also contains more than 180 substances including amino acids, vitamins, minerals and enzymes. Investigators hypothesized that supplementation of enteral feeds with honey would produce a bifidogenic effect and stimulate the immune response in preterm infants. Investigators randomly assigned subjects to 4 groups receiving 0, 5, 10 and 15 grams of honey daily for 2 weeks and measured their effect on stool colonization, systemic immune parameters and anthropometric measurements.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2011

Typical duration for early_phase_1

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 3, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 10, 2016

Completed
Last Updated

February 10, 2016

Status Verified

February 1, 2016

Enrollment Period

3.2 years

First QC Date

February 3, 2016

Last Update Submit

February 9, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • The presence of Bifidobacterium bifidum and Lactobacillus spp in Stool

    Stool culture/ Gram Stain and quantitative real time PCR were used to for this outcome.

    Two weeks

Secondary Outcomes (4)

  • CD4 and CD8 concentration in the serum

    2 weeks

  • Change in Weight (gram)

    Baseline and 2 weeks

  • Change in crown-heel length (cm)

    Baseline and 2 weeks

  • Change in head circumference (cm)

    Baseline and 2 weeks

Study Arms (4)

Control 0

PLACEBO COMPARATOR

No Intervention. This group received Premature Milk Formula. This group did not receive any Medically-Graded Honey.

Other: Premature Milk Formula

Group 1

EXPERIMENTAL

This group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 5 gram/day) for 2 weeks

Dietary Supplement: Medically-Graded HoneyOther: Premature Milk Formula

Group 2

EXPERIMENTAL

This group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 10 gram/day) for 2 weeks

Dietary Supplement: Medically-Graded HoneyOther: Premature Milk Formula

Group 3

EXPERIMENTAL

This group received Premature Milk Formula. This group received Medically-Graded Honey (dose = 15 gram/day) for 2 weeks

Dietary Supplement: Medically-Graded HoneyOther: Premature Milk Formula

Interventions

Medically-Graded HoneyDIETARY_SUPPLEMENT

Honey added to the baby formula once a day for 2 weeks.

Group 1Group 2Group 3

Enteral feeds were provided to subjects of all groups using premature milk formula as per routine nutritional management in the neonatal intensive care unit.

Control 0Group 1Group 2Group 3

Eligibility Criteria

Age3 Days - 3 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm infants with gestational age ≤ 34 weeks
  • postnatal age \> 3 days
  • no previous enteral feeding, and
  • parental wish to use milk formula with no intention to use breast milk or breastfeed.

You may not qualify if:

  • infants with major chromosomal abnormalities
  • Infant with major congenital anomalies of the cardiovascular, pulmonary or central nervous system; including neuromuscular disorders and neural tube defects
  • infants with intestinal atresia, tracheoesophageal fistulas, omphalocele, gastroschisis, and other major congenital GI anomalies, and
  • infants with sepsis, either before or during enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Boyar V, Handa D, Clemens K, Shimborske D. Clinical experience with Leptospermum honey use for treatment of hard to heal neonatal wounds: case series. J Perinatol. 2014 Feb;34(2):161-3. doi: 10.1038/jp.2013.158.

  • Eteraf-Oskouei T, Najafi M. Traditional and modern uses of natural honey in human diseases: a review. Iran J Basic Med Sci. 2013 Jun;16(6):731-42.

  • Ezz El-Arab AM, Girgis SM, Hegazy EM, Abd El-Khalek AB. Effect of dietary honey on intestinal microflora and toxicity of mycotoxins in mice. BMC Complement Altern Med. 2006 Mar 14;6:6. doi: 10.1186/1472-6882-6-6.

  • Kapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev. 2007 May;83(5):335-9. doi: 10.1016/j.earlhumdev.2006.07.003. Epub 2006 Sep 14.

  • Aly H, Said RN, Wali IE, Elwakkad A, Soliman Y, Awad AR, Shawky MA, Alam MSA, Mohamed MA. Medically Graded Honey Supplementation Formula to Preterm Infants as a Prebiotic: A Randomized Controlled Trial. J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):966-970. doi: 10.1097/MPG.0000000000001597.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

February 3, 2016

First Posted

February 10, 2016

Study Start

January 1, 2011

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

February 10, 2016

Record last verified: 2016-02